ATE183202T1 - Pasteurella multocida toxoid enthaltende impfstoffe - Google Patents

Pasteurella multocida toxoid enthaltende impfstoffe

Info

Publication number
ATE183202T1
ATE183202T1 AT91913518T AT91913518T ATE183202T1 AT E183202 T1 ATE183202 T1 AT E183202T1 AT 91913518 T AT91913518 T AT 91913518T AT 91913518 T AT91913518 T AT 91913518T AT E183202 T1 ATE183202 T1 AT E183202T1
Authority
AT
Austria
Prior art keywords
toxoid
pasteurella multocida
multocida
vaccines containing
methods
Prior art date
Application number
AT91913518T
Other languages
English (en)
Inventor
Joseph C Frantz
David S Roberts
Leroy A Swearingin
Richard J Kemmy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE183202T1 publication Critical patent/ATE183202T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91913518T 1990-06-13 1991-06-10 Pasteurella multocida toxoid enthaltende impfstoffe ATE183202T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53745490A 1990-06-13 1990-06-13

Publications (1)

Publication Number Publication Date
ATE183202T1 true ATE183202T1 (de) 1999-08-15

Family

ID=24142703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913518T ATE183202T1 (de) 1990-06-13 1991-06-10 Pasteurella multocida toxoid enthaltende impfstoffe

Country Status (10)

Country Link
US (1) US5536496A (de)
EP (1) EP0651609B1 (de)
JP (1) JP3178720B2 (de)
AT (1) ATE183202T1 (de)
AU (2) AU8195391A (de)
DE (1) DE69131525T2 (de)
DK (1) DK0651609T3 (de)
ES (1) ES2136064T3 (de)
GR (1) GR3031487T3 (de)
WO (1) WO1991019419A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU669681B2 (en) * 1991-11-15 1996-06-20 Pfizer Inc. Pasteurella multocida toxoid vaccines
DK0669971T3 (da) * 1991-11-15 2003-04-22 Pfizer Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
CA2192165A1 (en) * 1994-06-10 1995-12-21 Toru Kawai Process for purifying necrotoxin produced by bordetella and toxoid
US7626017B2 (en) * 1997-10-31 2009-12-01 Pressure Biosciences, Inc. Pressure-enhanced extraction and purification
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6517844B1 (en) * 1999-05-14 2003-02-11 Marshall K. Brinton Compositions and method for immunizing polutry
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
WO2019023674A1 (en) * 2017-07-28 2019-01-31 Mccabe James G MULTIPURPOSE VENOUS VACCINES
US11446367B2 (en) * 2017-07-28 2022-09-20 Zootoxins, Llc Immunization with polyvalent venom vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine

Also Published As

Publication number Publication date
GR3031487T3 (en) 2000-01-31
JP3178720B2 (ja) 2001-06-25
JPH05508407A (ja) 1993-11-25
EP0651609A1 (de) 1995-05-10
DE69131525D1 (de) 1999-09-16
DK0651609T3 (da) 1999-12-06
EP0651609B1 (de) 1999-08-11
AU685569B2 (en) 1998-01-22
EP0651609A4 (de) 1993-06-30
ES2136064T3 (es) 1999-11-16
DE69131525T2 (de) 1999-11-25
AU8195391A (en) 1992-01-07
AU1362895A (en) 1995-08-10
US5536496A (en) 1996-07-16
WO1991019419A1 (en) 1991-12-26

Similar Documents

Publication Publication Date Title
DE69728380D1 (de) Streptokokken c5a peptidase impfstoff
CA2089552A1 (en) Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
DE69331901D1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
DE69131525D1 (de) Pasteurella multocida toxoid enthaltende impfstoffe
CY1106983T1 (el) ΕΜΒΟΛΙΟ ΠΕΠΤΙΔΑΣΗΣ C5a ΣΤΡΕΠΤΟΚΟΚΚΟΥ
DK22389A (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
DK0639640T3 (da) Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
DE69113991T2 (de) Impfstoff.
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
EP0529019A4 (en) Nematode vaccine
CA2086258A1 (en) Pasteurella multocida toxoid vaccines
CA2312296A1 (en) Pasteurella multocida toxoid vaccines
GB9018061D0 (en) Compositions for vaccines
ATE258445T1 (de) Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1
NL7810753A (nl) Gecombineerd vaccin voor immunisering tegen infecties door haemophilus influenza, type b.
IT8722791A0 (it) Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
RU93005000A (ru) Композиция вакцин, способ ее получения, способ исключения иммунной реакции
MX9604262A (es) Antigenos de pasteurellaceae y vacunas relacionadas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time